A
FULC icon

AJOVista’s Fulcrum Therapeutics FULC Stock Holding History

AJOVista’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$65.5K Buy
+18,349
New +$136K 0.28% 90

Other funds holding FULC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AJOVista's FULC Position: Q3 2024 in Review

AJOVista opened a new position in Fulcrum Therapeutics (FULC) in Q3 2024: 18,349 shares worth $65.5K. The stake represents 0.28% of the portfolio and ranks #90 among its holdings.

130 funds tracked by Wall St. Rank hold FULC as of Q3 2024.

  • AJOVista held 18,349 shares of Fulcrum Therapeutics worth $65.5K as of Q3 2024.
  • Fulcrum Therapeutics was a new AJOVista position in Q3 2024.
  • Fulcrum Therapeutics made up 0.28% of AJOVista's portfolio in Q3 2024, its #90 holding.
  • 130 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2024.

Based on AJOVista's 13F filing for Q3 2024, filed 12 Nov 2024.